ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 431,04
-0,79%
Dow Jones
41 887,31
-1,75%
DAX
20 214,79
-0,51%
Brent Oil
78,87
2,53%
Bitcoin
93 465,25
1,14%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Talphera Inc (TLPH) Cours

Talphera Inc

Talphera Inc (TLPH)

NASDAQ
0,59
0,0091
( 1,57% )
Mis à jour : 17:48:28
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
0,59
Prix Achat
0,56
Prix Vente
0,59
Volume échangé
61 667
0,5502 Fourchette du Jour 0,59
0,501 Plage de 52 semaines 1,61
Cap du marché
10,047M
Clôture Veille
0,5809
Ouverture
0,57
Dernière Transaction
250
@
0.59
Dernière heure de transaction
17:48:28
Volume financier
US$ 34 845
VWAP
0,565057
Volume moyen (3 m)
97 650
Actions en circulation
17 029 218
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,52
Bénéfice par action (BPA)
-1,08
Chiffre d'affairess
651k
Bénéfice net
-18,4M

À propos de Talphera Inc

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-... AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
talphera.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Talphera Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker TLPH. Le dernier cours de clôture d'Talphera était de US$0,58. Au cours de la dernière année, les actions de Talphera ont été négociées dans une fourchette de prix de US$ 0,501 à US$ 1,61.

Talphera compte actuellement 17 029 218 actions en circulation. La capitalisation boursière d'Talphera est de US$9,89 million. Talphera a un ratio cours/bénéfice (ratio PE) de -0.52.

TLPH Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

11 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

06 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

02 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

02 Décembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

02 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

29 Novembre 2024
Edgar (US Regulatory)

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors PR Newswire ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2024 ROCKVILLE, Md. and SUZHOU...

25 Novembre 2024
PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

13 Novembre 2024
Edgar (US Regulatory)

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire SAN MATEO, Calif., Nov. 13, 2024 Five sites actively screening with multiple patients having...

13 Novembre 2024
PR Newswire (US)

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024 PR Newswire SAN MATEO, Calif., Nov. 6, 2024 SAN MATEO, Calif., Nov. 6...

06 Novembre 2024
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.0001-0.01694628029150.59010.650.55921510.61561706CS
4-0.07-10.60606060610.660.68960.5011248910.5696683CS
12-0.47-44.33962264151.061.150.501976500.70820299CS
26-0.34-36.55913978490.931.190.501896750.84565949CS
52-0.27-31.39534883720.861.610.501924360.96441074CS
156-0.27-31.39534883720.861.610.501924360.96441074CS
260-0.27-31.39534883720.861.610.501924360.96441074CS

TLPH - Frequently Asked Questions (FAQ)

What is the current Talphera share price?
The current share price of Talphera is US$ 0,59
How many Talphera shares are in issue?
Talphera has 17 029 218 shares in issue
What is the market cap of Talphera?
The market capitalisation of Talphera is USD 9,89M
What is the 1 year trading range for Talphera share price?
Talphera has traded in the range of US$ 0,501 to US$ 1,61 during the past year
What is the PE ratio of Talphera?
The price to earnings ratio of Talphera is -0,52
What is the cash to sales ratio of Talphera?
The cash to sales ratio of Talphera is 14,66
What is the reporting currency for Talphera?
Talphera reports financial results in USD
What is the latest annual turnover for Talphera?
The latest annual turnover of Talphera is USD 651k
What is the latest annual profit for Talphera?
The latest annual profit of Talphera is USD -18,4M
What is the registered address of Talphera?
The registered address for Talphera is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Talphera website address?
The website address for Talphera is talphera.com
Which industry sector does Talphera operate in?
Talphera operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SHOTWSafety Shot Inc
US$ 0,2303
(130,30%)
4,14k
DATSDatChat Inc
US$ 6,60
(105,61%)
85,39M
GLXGGalaxy Payroll Group Ltd
US$ 1,80
(91,49%)
33,53M
VMARVision Marine Technologies Inc
US$ 2,6131
(71,91%)
155,08M
CDTConduit Pharmaceuticals Inc
US$ 0,1246
(51,95%)
949,64M
IGMSIGM Biosciences Inc
US$ 1,945
(-68,63%)
3,14M
XTIAXTI Aerospace Inc
US$ 5,8036
(-54,03%)
3,6M
AIFUAIX Inc
US$ 0,4349
(-45,98%)
2,93M
MODVModivCare Inc
US$ 7,465
(-40,23%)
1,07M
XXII22nd Century Group Inc
US$ 4,9794
(-38,53%)
216,11k
CDTConduit Pharmaceuticals Inc
US$ 0,1242
(51,46%)
949,96M
VMARVision Marine Technologies Inc
US$ 2,5984
(70,95%)
155,13M
RGTIRigetti Computing Inc
US$ 10,088
(0,48%)
114,16M
NVDANVIDIA Corporation
US$ 135,9289
(-2,98%)
107,3M
DATSDatChat Inc
US$ 6,6401
(106,86%)
85,59M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
TLPH
Talphera
USOTC
ANKM
ANKAM (QB)
EU
BNPGB
BNP Paribas 1.25% 19mar2...
NASDAQI
AUX
ISE Australian Dollar FX...
EU
FR001400SNS6
BPI France Bpi 3.875% 22...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés